Subcutaneous formulations of anti-CD38 antibodies and their uses | Patent Number 11566079

US 11566079 B2
Application Number16840153
Publication NumberUS 20200231697 A1
Pendency2 years, 10 months, 3 days
Filled DateApr 3, 2020
Priority DateNov 3, 2015
Publication DateJul 23, 2020
Expiration DateNov 2, 2035
Inventor/ApplicantsVineet Kumar
Richard Jansson
ExaminesROARK, JESSICA HOPE
Art Unit1643
Technology Center1600
Assignments
Janssen Biotech Inc.
Current
Janssen Biotech Inc.Johnson & Johnson
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
See the invalidated claims, subscribe to our Concierge Program.
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.